Healthcare provider profile · identity verified

Eugenio Espinosa

Nurse Practitioner · MIAMI, FL · NPI 1811474240

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	335	130
Losartan Potassium	Losartan Potassium	334	114
Metformin Hcl	Metformin Hcl	309	113
Gabapentin	Gabapentin	276	102
Amlodipine Besylate	Amlodipine Besylate	270	90
Lisinopril	Lisinopril	259	87
Vitamin D2	Ergocalciferol (Vitamin D2)	245	53
Glipizide	Glipizide	183	58
Omeprazole	Omeprazole	181	72
Levothyroxine Sodium	Levothyroxine Sodium	170	69
Ciclopirox	Ciclopirox	166	51
Hydrochlorothiazide	Hydrochlorothiazide	149	54
Rosuvastatin Calcium	Rosuvastatin Calcium	138	63
Metoprolol Succinate	Metoprolol Succinate	136	45
Tamsulosin Hcl	Tamsulosin Hcl	134	47
Memantine Hcl	Memantine Hcl	126	48
Pantoprazole Sodium	Pantoprazole Sodium	123	42
Metoprolol Tartrate	Metoprolol Tartrate	109	38
Simvastatin	Simvastatin	103	33
Montelukast Sodium	Montelukast Sodium	100	36
Clopidogrel	Clopidogrel Bisulfate	98	39
Alendronate Sodium	Alendronate Sodium	95	38
Famotidine	Famotidine	95	36
Albuterol Sulfate Hfa	Albuterol Sulfate	91	38
Escitalopram Oxalate	Escitalopram Oxalate	89	32
Quetiapine Fumarate	Quetiapine Fumarate	88	28
Folic Acid	Folic Acid	84	18
Trazodone Hcl	Trazodone Hcl	83	30
Carvedilol	Carvedilol	82	28
Naproxen	Naproxen	81	58
Latanoprost	Latanoprost	74	22
Mirtazapine	Mirtazapine	72	31
Sertraline Hcl	Sertraline Hcl	72	23
Sildenafil Citrate	Sildenafil Citrate	72	19
Azithromycin	Azithromycin	71	60
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	70	53
Furosemide	Furosemide	68	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	18
Januvia	Sitagliptin Phosphate	59	17
Gemfibrozil	Gemfibrozil	57	22
Enalapril Maleate	Enalapril Maleate	56	16
Donepezil Hcl	Donepezil Hcl	55	21
Fluticasone Propionate	Fluticasone Propionate	55	21
Alprazolam	Alprazolam	54	18
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	54	14
Eliquis	Apixaban	54	15
Meclizine Hcl	Meclizine Hcl	54	24
Nifedipine Er	Nifedipine	52	18
Baclofen	Baclofen	50	32
Atenolol	Atenolol	49	16
Ciclopirox	Ciclopirox Olamine	47	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	15
Clonazepam	Clonazepam	46	suppressed
Ketoconazole	Ketoconazole	44	16
Pioglitazone Hcl	Pioglitazone Hcl	44	13
Ammonium Lactate	Ammonium Lactate	42	15
Temazepam	Temazepam	42	11
Tadalafil	Tadalafil	41	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	37	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Chlorthalidone	Chlorthalidone	35	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	34	22
Ibuprofen	Ibuprofen	34	25
Benzonatate	Benzonatate	33	25
Ulticare Pen Needle	Pen Needle, Diabetic	33	suppressed
Entresto	Sacubitril/Valsartan	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	17
Citalopram Hbr	Citalopram Hydrobromide	27	12
Methylprednisolone	Methylprednisolone	27	21
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	21
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	12
Glimepiride	Glimepiride	23	11
Lactulose	Lactulose	23	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	23	12
Propranolol Hcl	Propranolol Hcl	22	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Levofloxacin	Levofloxacin	20	18
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	13
Dutasteride	Dutasteride	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Atrovent Hfa	Ipratropium Bromide	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Lumigan	Bimatoprost	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Combigan	Brimonidine Tartrate/Timolol	11	suppressed
Finasteride	Finasteride	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Unifine Pentips	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error